You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Drug Formulary
About the Drug Formulary Email Drug Formulary Team

CISPVINO

Cancer Type: Lung, Non-Small Cell      Intent: Palliative
Regimen Category: Evidence-Informed
Drugs Used:
CISplatin,
vinorelbine
... Show more tags
Funding:
New Drug Funding Program
    Vinorelbine - Non-Small Cell Lung Cancer (NSCLC)
... Show more tags

Regimen Monograph

Jan 2018
Table of Contents

Patient Info Sheet

May 2016

CISplatin-Vinorelbine is a drug combination for treating non-small cell lung cancer.

You might also be interested in

GEMC

CISPETOP(RT)

Symptom Management

Many people living with cancer experience nausea, diarrhea and other symptoms from their treatment or disease.

View Symptom Management

Drug Safety and Administration

Find documents on drug safety and administration for healthcare providers, including calculations and recommendations.

View Drug Safety and Administration